Hong Kong Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Hong Kong Pharmaceuticals and Healthcare Report Q3 2013 May 22nd 2013, 00:00 BMI View: Hong Kong’s attractiveness as a pharmaceutical market hinges largely on its ageing and affluent demographics, its proximity to China as well as the stable political and economic environment. However we highlight that its long-term attractiveness is limited by its small market size and the increasing openness of the Chinese market, which decreases the necessity for firms to set up bases in Hong Kong. Headline Expenditure Projections ? Pharmaceuticals: HKD10.31bn (US$1.33bn) in 2012 to HKD10.77bn (US$1.39bn) in 2013; +4.5% in local currency terms and +4.3% in US dollar terms. Forecast broadly in line with Q212. ? Healthcare: HKD112.38bn (US$14.49bn) … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=97313. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/hong-kong-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions